Literature DB >> 13054894

The clinical significance of the emergence of drug-resistant organisms during the therapy of chronic pulmonary tuberculosis with hydrazides of isonicotinic acid.

E O COATES, G M MEADE, W STEENKEN, E WOLINSKY, G L BRINKMAN.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1953        PMID： 13054894     DOI： 10.1056/NEJM195306252482601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND
Journal:  Thorax       Date:  1955-06       Impact factor: 9.139

2.  CHANGES in isoniazid resistance of tubercle bacilli after cessation of treatment; report by the Laboratory Subcommittee of the Tuberculosis Chemotherapy Trials Committee, Medical Research Council; M.R.C. isoniazid trial: Report No. 6.

Authors: 
Journal:  Thorax       Date:  1954-12       Impact factor: 9.139

Review 3.  Minority variants of drug-resistant HIV.

Authors:  Sara Gianella; Douglas D Richman
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.